However, it has been reported that the inhibition of the MAPK pathway can upregulate the PD-L1 expression, decrease IL-6 and IL-8 secretion, and increase the tumor-infiltrating lymphocytes in melanoma patients (61). The gene discussed is CD274; the disease is neoplasm.